Evidence map›Paper›PMID 24945320›Full record

ArticlePloS one2014

A dimerized HMX1 inhibits EPHA6/epha4b in mouse and zebrafish retinas.

Fabienne Marcelli, Gaëlle Boisset, Daniel F Schorderet

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Fabienne MarcelliIRO - Institute for Research in Ophthalmology, Sion, Switzerland; Faculty of Life Sciences, Swiss Federal Institute of Technology (EPFL), Lausanne, Switzerland.
Gaëlle BoissetIRO - Institute for Research in Ophthalmology, Sion, Switzerland.
Daniel F SchorderetIRO - Institute for Research in Ophthalmology, Sion, Switzerland; Faculty of Life Sciences, Swiss Federal Institute of Technology (EPFL), Lausanne, Switzerland; Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.
École Polytechnique Fédérale de Lausanne · CHInstitut de Recherche en Opthalmologie · CHUniversity of Lausanne · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

HMX1 is a homeobox-containing transcription factor implicated in eye development and responsible for the oculo-auricular syndrome of Schorderet-Munier-Franceschetti. HMX1 is composed of two exons with three conserved domains in exon 2, a homeobox and two domains called SD1 and SD2. The function of the latter two domains remains unknown. During retinal development, HMX1 is expressed in a polarized manner and thus seems to play a role in the establishment of retinal polarity although its exact role and mode of action in eye development are unknown. Here, we demonstrated that HMX1 dimerized and that the SD1 and homeodomains are required for this function. In addition, we showed that proper nuclear localization requires the presence of the homeodomain. We also identified that EPHA6, a gene implicated in retinal axon guidance, is one of its targets in eye development and showed that a dimerized HMX1 is needed to inhibit EPHA6 expression.

Indexed as

Protein MultimerizationAnimalsCell NucleusGreen Fluorescent ProteinsHEK293 CellsHomeodomain ProteinsHumansMice, Inbred C57BLMutant ProteinsPromoter Regions, GeneticProtein Structure, TertiaryProtein TransportReceptor, EphA4Receptor, EphA6RetinaTranscription FactorsGreen Fluorescent ProteinsHomeodomain ProteinsMutant ProteinsNKX5-3 protein, mouseReceptor, EphA4Receptor, EphA6Transcription FactorsZebrafish Proteins

Identifiers

PMID24945320
PMCPMC4063770
OpenAlexW2071608659

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.